Next Article in Journal
Meroterpenoids and Isocoumarinoids from a Myrothecium Fungus Associated with Apocynum venetum
Previous Article in Journal
Aurantoside C Targets and Induces Apoptosis in Triple Negative Breast Cancer Cells
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Marine Drugs
Volume 16
Issue 10
10.3390/md16100362
marinedrugs-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Biological and Chemical Diversity of Ascidian-Associated Microorganisms

by
Lei Chen
1,*,
Jin-Shuang Hu
1,
Jia-Lei Xu
1,
Chang-Lun Shao
2 and
Guang-Yu Wang
1,*
1
Department of Bioengineering, School of Marine Science and Technology, Harbin Institute of Technology, Weihai 264209, China
2
Laboratory of Marine Drugs, The Ministry of Education of China, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China
*
Authors to whom correspondence should be addressed.
Mar. Drugs 2018, 16(10), 362; https://doi.org/10.3390/md16100362
Submission received: 14 September 2018 / Revised: 23 September 2018 / Accepted: 27 September 2018 / Published: 1 October 2018
Browse Figures
Versions Notes

Abstract

:
Ascidians are a class of sessile filter-feeding invertebrates, that provide unique and fertile niches harboring various microorganisms, such as bacteria, actinobacteria, cyanobacteria and fungi. Over 1000 natural products, including alkaloids, cyclic peptides, and polyketides, have been isolated from them, which display diverse properties, such as antibacterial, antifungal, antitumor, and anti-inflammatory activities. Strikingly, direct evidence has confirmed that ~8% of natural products from ascidians are actually produced by symbiotic microorganisms. In this review, we present 150 natural products from microorganisms associated with ascidians that have been reported up to 2017.

Graphical Abstract

1. Introduction

Ascidians are the most abundant and diverse class of the sub-phylum Tunicata, and more than 3000 species have been described. They have been found in diverse ecological niches, from shallow water to the deep sea [1]. Thousands of natural products have been isolated from ascidians; these include alkaloids, cyclic peptides, and polyketides [2,3]. Most of these secondary metabolites have diverse bioactivities, such as antibacterial, antifungal, antitumor and anti-inflammatory activities. In addition to the well-known molecules ecteinascidin (ET-743) and didemnin B, several other natural products or their derivatives (e.g., plitidepsin [4], midostaurin [5], lestaurtinib [6], edotecarin [7]) are also in clinical development. However, it has remained unclear whether these bioactive products were produced by ascidians themselves, or by ascidian-associated microorganisms [8,9].
Ascidians harbor rich microbial communities. The development of culture-independent methods has provided comprehensive information about ascidian microbial diversity [3]. In recent years, an increasing number of microorganisms associated with ascidians (including fungi, bacteria, actinobacteria, and cyanobacteria) have been isolated [10]. In this review, we mainly focus on ascidian-associated microorganisms that were isolated by culture-dependent methods.
Microorganisms associated with ascidians represent a potential source of natural products [11]. Many compounds isolated from ascidian-associated microorganisms are extremely potent [12,13,14]. Ecteinascidin 743 (or ET-743, or the trade name Yondelis) was originally isolated from the Ecteinascidia turbinata [15]. In 2007, it was approved for the treatment of advanced soft tissue sarcoma by EMEA. In 2011, with the help of metagenomic methods, it was proven that Candidatus Endoecteinascidia frumentensis was the actual producer of ET-743 [16]. Didemnin B, originally isolated from the Caribbean ascidian Trididemnum solidum [17] was the first marine natural product used in clinical research in the U.S. Recently, researchers have corroborated that didemnin B is produced by the bacterial strains Tistrella mobilis and Tistrella bauzanensis rather than the ascidians [18,19]. Strong evidence shows that ~8% natural products that were initially thought to originate from ascidians are actually produced by ascidian-associated microorganisms [20].
This review will focus on the biodiversity of ascidian-associated microorganisms, and the chemical structures and bioactive properties of the secondary metabolites isolated from these microorganisms.

2. Microorganisms Associated with Ascidians

2.1. Geographical Distribution of Microorganisms Associated with Ascidians

Ascidians are widely distributed in oceans around the world. Research on the biological and chemical diversity of microorganisms associated with ascidians has concentrated on the north temperate areas and tropical areas, including Pacific Ocean, Atlantic Ocean, and Indian Ocean. Among these locations, approximately 60% of the sampling sites are located on the southwest coast of the Pacific Ocean (Figure 1). Almost all of these samples are collected from depths shallower than 20 m, and none are from the deep sea.

2.2. Diversity of Culturable Microorganisms Associated with Ascidians

Ascidians provide unique ecological niches for a diverse range of microorganisms. The ascidians used for culturable microorganisms belong to 19 genera (Aplidium, Botryllus, Ciona, Cystodytes, Didemnum, Diplosoma, Ecteinascidia, Eudistoma, Halocynthia, Lissoclinum, Oxycorynia, Polycitonidae, Polyclinum, Polycarpa, Polysyncraton, Pycnoclavella, Stomozoa, Styela, and Trididemnum) of 10 families (Cionidae, Clavelinidae, Didemnidae, Perophoridae, Polycitoridae, Polyclinidae, Pycnoclavellidae, Pyuridae, Stomozoidae, and Styelidae). The dominant family is Didemnidae. The specific microorganism identity is determined strictly by the precise ascidian species, with which it co-exists [3].
Ascidians can be divided into colonial and solitary classes. Colonial ascidians consist of many small individuals, called zooids, and the whole ascidians were used as the samples for the isolation of microorganisms. Solitary ascidians live as separate individuals with larger bodies, and the corresponding microbial diversity within these diverse ascidian tissues is different [3]. Thus, microorganisms have been isolated from different ascidian tissues, such as the tunic, gonads, gut and pharynx.
To date, diverse microorganisms, such as fungi, bacteria, actinobacteria and cyanobacteria have been isolated from ascidians. Bacteria represent the most abundant class of ascidian-associated microorganisms, and exhibit a high degree of diversity. On the other hand, cyanobacteria have also been widely used to study the symbiosis between microorganisms and their ascidian counterparts.

2.2.1. Bacteria

Ascidians are associated with diverse bacterial populations, and there is species-selective pairing of ascidians and bacteria [21]. For example, bacteria Acinetobacter sp. were isolated from the surface of Stomozoa murrayi [12], and bacteria Candidatus Endoecteinascidia frumentensis was found in symbiosis with Ecteinascidia turbinate [16], whereas Trididemnum solidum harbours the bacteria Tistrella mobilis and Tistrella bauzanensis [18,19]. To date, 21 genera belonging to 16 families in four phyla have been cultured from ascidians (Table 1). They are genus Acinetobacter belonging to family Moraxellaceae; genus Agrobacterium belonging to family Rhizobiaceae; genus Candidatus Endoecteinascidia belonging to an unclassified family; genus Candidatus Endolissoclinum and Tistrella belonging to family Rhodospirillaceae; genus Endozoicomonas belonging to family Endozoicomonadaceae; genus Halomonas belonging to family Halomonadaceae; genus Hasllibacter, Pseudovibrio, Ruegeria, and Stappia belonging to family Rhodobacteraceae; genus Pseudomonas belonging to family Pseudomonadaceae; genus Vibrio belonging to family Vibrionaceae in the phylum Proteobacteria; genus Bacillus and Paucisalibacillus belonging to family Bacillaceae; genus Paenibacillus belonging to family Paenibacillaceae; genus Staphylococus belonging to family Staphylococcaceae; genus Exiguobacterium belonging to unclassified family in phylum Firmicutes; genus Rubritalea belonging to family Rubritaleaceae in phylum Verrucomicrobia; genus Labilibacter belonging to family Marinilabiliaceae and genus Tenacibaculum belonging to family Flavobacteriaceae in phylum Bacteroidetes. The dominant phylum of Proteobacteria is represented by 13 genera, which belong to 9 families. Ascidian genus Didemnum showed high bacterial diversity, and nearly half of the bacterial genera mentioned in this paper (Acinetobacter, Bacillus, Endozoicomonas, Exiguobacterium, Paenibacillus, Paucisalibacillus, Pseudomonas, Pseudovibrio, Ruegeria, Staphylococus, Stappia and Vibrio) were isolated from them. Surprisingly, culture-dependent and -independent approaches have not often been used to study the symbiosis between bacteria and ascidians, and further work is required in this area [22].

2.2.2. Actinobacteria

The bacterial phylum of Actinobacteria is widely known for the ability to produce bioactive compounds. Marine actinobacteria are widely distributed across different marine ecosystems, such as sediments, water, mangrove, algae, and animals [23,24,25,26]. As is the case with marine invertebrate sponges and corals, ascidians are associated with rich and diverse actinobacteria communities.
A total of 16 genera, belonging to 11 families of phylum Actinobacteria have been isolated from 14 kinds of ascidians (Table 1). Streptomyces was the dominant genus and could be found in many ascidians. Fifteen rare actinobacterial genera (Actinomadura, Aeromicrobium, Arthrobacter, Brevibacterium, Curtobacterium, Gordonia, Kocuria, Micrococcus, Micromonospora, Nocardia, Nocardiopsis, Saccharopolyspora, Salinispora, Solwaraspora and Verrucosispora), have also been isolated from various host ascidians.

2.2.3. Cyanobacteria

Cyanobacteria is a phylum of bacteria that produce oxygen during photosynthesis. In 1982, Kott discovered the symbiotic relationship between cyanobacteria and 20 ascidian species. Of these, 17 ascidian species are obligate associates with the symbiotic cyanobacteria genus Prochloron, and the other three species (Trididemnum solidum, T. Cyanophorum and Didemnum viride) are associated with the cyanobacteria genus Synechocystis [27] (Table 1). Most host ascidians that exhibit symbiosis with the cyanobacteria, Prochloron, belong to the Didemnidae family, and are called ‘Didemnid ascidians’. The Didemnidae family also includes some non-symbiotic ascidian species. Genus Prochloron is the most representative ascidian symbiont, with Prochloron didemni being the sole species in this genus [28]. Cyanobacteria symbionts can both provide nutrients and participate in defence for the ascidian host by means of carbon fixation, nitrogen recycling and metabolite production. In return, the ascidian host can provide some of the nitrogen-containing nutrients that are required for growth of cyanobacteria symbionts, and protect them from ultraviolet radiation [28].

2.2.4. Fungi

The ascidian-associated fungi belong to 25 genera of 19 families in two phyla (Table 1). Most of them belong to the Phylum Ascomycota, which encompasses 22 genera (Acremonium, Alternaria, Aspergillus, Bionectria, Botryosphaeria, Botrytis, Cladosporium, Clonostachys, Cochliobolus, Epicoccum, Fusarium, Humicola, Meyerozyma, Microdiplodia, Penicillium, Pestalotiopsis, Pithomyces, Phoma, Plectosphaerella, Scopulariopsis, Talaromyces and Trichoderma). The dominant genus is Penicillium, followed by Aspergillus, Cladosporium, Talaromyces and Trichoderma. The host ascidians can be classified into 10 genera, of which the dominant genera are Cystodytes, Pycnoclavell, and Didemnum. Host specificity of ascidian-associated fungi is not apparent, and thus the significance of fungi for ascidians and their possible ecological roles remain unclear [29].

3. Structure and Bioactivities of Natural Products

To date, 150 natural products have been isolated from ascidian-associated microorganisms. These compounds include polyketides, terpenoids, peptides, and alkaloids. These natural products have diverse properties, such as antimicrobial, antitumor and anti-inflammatory activities.

3.1. Polyketides

Polyketides, including macrolides, anthraquinones and polyethers, are derived from the polymerization of acetyl and propionyl groups, and are biosynthesized by three types of polyketide synthases (PKSs). Type I PKSs are multifunctional enzymes, type II PKSs are multienzyme complexes, and type III PKSs are homodimeric enzymes, which are also referred to as ‘chalcone synthase-like PKSs’ [88]. Thirty-seven of the compounds under review here (24.7%) are polyketide-based, and many of them have biological and pharmacological activities.
The antimelanoma drug palmerolide A (1) (Figure 2), a new enamide-bearing polyketide, was isolated from Synoicum adareanum, and was possibly of bacterial origin [89]. It has potent cytotoxicity against melanoma cells (UACC-62, MI14, SK-MEL-5, LOX IMVI), colon cancer cell line HCC-2998 and renal cancer cell line RXF 393. It was also found to be V-ATPase inhibitor [90,91]. Another ascidian, Lissoclinum patella, produces patellazoles A–C (2–4); these natural compounds have strong cytotoxicity against HCT-116 tumour cells [92]. Chemical and biological evidence suggested that the bacterium Candidatus Endolissoclinum faulkneri synthesizes patellazoles [34]. Further studies indicate that these products were the foundation of the symbiotic relationship between ascidians and bacteria, and were conserved even during the drive of genome reduction over millions of years [93].
The ascidian-associated bacterium, Streptomyces sp. PTY087I2, exhibited enhanced production of three naphthoquinone derivatives, granaticin (5), granatomycin D (6), and dihydrogranaticin B (7), and increased antibacterial activity when co-cultured with the human pathogens Bacillus subtilis, methicillin-sensitive Staphylococcus aureus (MSSA), methicillin-resistant Staphylococcus aureus (MRSA), and Pseudomonas aeruginosa) [63]. The isolation of Streptomyces sp. #N1-78-1 from Ecteinascidia turbinata in Puerto Rico led to the purification of bisanthraquinones 1 and 2 (8, 9), and derivative 3 (10), the dehydration product of bisanthraquinone 1. Bisanthraquinones 1 and 2 showed potent antimicrobial activities against MRSA (methicillin-resistant Staphylococcus aureus) and VRE (vancomycin-resistant Enterococcus faecalis), and these three compounds displayed cytotoxic activity against HCT-116 cells [13]. Two novel chlorinated pyrones, halomadurones A and B (11, 12), and two novel brominated analogues, halomadurones C and D (13, 14) were isolated from Actinomadura sp. strain WMMB499 associated with Ecteinascidia turbinata in the Florida Keys. Halomadurones C and D showed potent nuclear factor E2-related factor antioxidant response element (Nrf2-ARE) activation, but were toxic at high concentrations [46]. Arenimycin (15) was the first report of the benzo[α] naphthacene quinone class of antibiotic isolated from marine actinobacteria Salinispora arenicola strain CNR-647, which is associated with Ecteinascidia turbinate. Arenimycin exhibited potent antimicrobial activities against drug-resistant Staphylococci, some other Gram-positive microorganisms and one Mycobacterium strain [14]. Ubiquinone Q9 (16), which was determined as 2,3-dimethoxy-5-methyl-6-polyprenyl-1,4-benzoquinone by NMR spectroscopy and mass spectrometry, has been isolated from Nocardia sp. strain KMM 3749, a bacterium associated with an unidentified ascidian. This compound inhibited the development of fertilized eggs from the sea urchin Strongylocentrotus intermedius and caused haemolysis of mouse erythrocytes [52]. Griseorhodin A (17), a member of the rubromycin family, is an inhibitor of human telomerase [94]. The biosynthesis gene cluster for griseorhodin A was isolated from Streptomyces sp. JP95, which is associated with Aplidium lenticulum collected at Heron Island, Queensland, Australia [60]. In order to find the actual producer of namenamicin, a potent antitumour compound isolated from Polysyncraton lithostrotum, a number of actinobacteria were isolated from the inner core of the host ascidian. Among them, the actinobacteria Salinispora pacifica (originally proposed to be Micromonospora lomaivitiensis), strain LL-37I366 produced two novel lomaiviticin compounds, A and B (18, 19). These natural products, which are members of the angucycline family of aromatic polyketides, contain a distinctive diazotetrahydrobenzo[b]fluorene scaffold also found in the kinamycins [56]. Both compounds were demonstrated to be potent DNA damaging agents by biochemical induction assay (BIA), and have antimicrobial activities against Staphylococcus aureus and Enterococcus faecium. Lomaiviticin A also showed cytotoxicity against a number of cancer cell lines [55]. The actinobacteria Streptomyces coelicoflavus strain HQA809, which is associated with Styela clava, produced two natural compounds, germicidin (20) and 6-isopropyl group-3-ethyl-4-hydroxy-2-pyrone (21). Both of these compounds were lethal to Artemia salina [53]. The isolation of Actinomadura sp. from Ecteinascidia turbinata led to the purification of ecteinamycin (22). It showed potent antimicrobial activity against Clostridium difficile NAP1/B1/027 [47].
Pitholides A–D (23–26) and (R)-5-methylmellein (27) were isolated from the fungus Pithomyces sp., which is associated with Oxycorynia fascicularis collected from Indo-Pacific. The bioactivities of pitholides A–D (23–26) were not mentioned, but (R)-5-methylmellein (27) was lethal in a brine shrimp assay [81]. Yanuthones A–E (28–32) together with 1-hydroxyyanuthone A (33), 1-hydroxyyanuthone C (34), and 22-deacetylyanuthone A (35) were isolated from the fungus Aspergillus niger, which is associated with Aplidium sp. The yanuthones showed weak antimicrobial activities against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus sp. The mixed routes for yanuthone biosynthesis imparts structural diversity to this class of compounds [74]. The total synthesis of yanuthones A–C and 22-deacetylyanuthone A has been accomplished following a short regio- and stereocontrolled approach involving the key intermediate, 2-farnesyl-p-benzoquinone [95]. A known benzophenone derivative, monodictyphenone (36) was isolated from an Indonesian ascidian-associated Penicillium albobiverticillium TPU1432, and exhibited moderate inhibitory activities against protein tyrosine phosphatase (PTP) 1B, T cell PTP (TCPTP), CD45 tyrosine phosphatase (CD45), and vaccinia H-1-related phosphatase (VHR) [82]. Monodictyphenone (36) was previously isolated from the fungal strain Monodictys putredinis, which in turn is associated with a marine green alga [96]. A novel filamentous fungus, in the class Eurotiomycetes strain 110162 was isolated from Lissoclinum patella collected in Papua New Guinea. A racemic, prenylated polyketide dimer, oxazinin A (37), was isolated from this fungus, and was composed of a unique combination of benzoxazine, isoquinoline, and a pyran ring. Oxazinin A showed antimycobacterial activity against Mycobacterium tuberculosis, cytotoxic activity against human CEM-TART T-cell leukemia line and modestly antagonized the activity of transient receptor potential (TRP) channels [87].

3.2. Terpenoids and Meroterpenoids

The terpenoids are derived from five-carbon isoprene units assembled and modified in thousands of ways, as well as their oxygen-containing derivatives. Terpenes are generally considered to be plant metabolites, although more and more terpenoids are isolated from marine microorganism [97]. The number of terpenoids reported from ascidian-associated microorganisms is very small and most of them are sesquiterpenoids, and these compounds showed diverse bioactivities. The meroterpenoids are natural products of mixed biosynthetic origin, which are partially derived from terpenoids.
Two new terpenoids gifhornenolones A (38) and B (39), together with a known sesquiterpene compound cyperusol C (40) were isolated from actinobacterial strain Verrucosispora gifhornensis YM28-088 associated with ascidian. However, only gifhornenolone A was reported to have potent inhibitory activity against the androgen receptor [98].
Didemnum molle was the source of fungus Penicillium sp. strain SS080624SCf1, and this strain produced two novel sesquiterpenoids JBIR-27 (41) and JBIR-28 (42), together with two known compounds sporogen-AO1 (43) and phomenone (44). They showed cytotoxicity against HeLa expect for JBIR-27 [80]. The fungus Humicola fuscoatra strain KMM 4629 associated with ascidian produced a new sesquiterpene of the caryophyllene series, fuscoatrol A (45), and a known compound 11-epiter-pestacin (46). This is the first report of fuscoatrol A, but its acetyl form, pestalotiopsin B, has been isolated from the endophytic fungus associated with the bark and the leaves of Taxus brevifolia. These two compounds both showed antimicrobial activities against Staphylococcus aureus and Bacillus subtilis, and fuscoatrol A also exhibited cytotoxic action on the developing eggs of sea urchin Strongylocentrotus intermedius [76].
Two new merosesquiterpenes, verruculides A and B (47, 48), together with chrodrimanins A (49), B (50) and H (51) were all isolated from Talaromyces verruculosus (basionym: Penicillium verruculosum) strain TPU1311 associated with Polycarpa aurata. Compounds 47, 49 and 51 inhibited the activity of protein tyrosine phosphatase 1B (PTP1B). This was the first study to demonstrate chrodrimanin family as PTP1B inhibitors [84].

3.3. Peptides

Peptides isolated from ascidian-associated microorganisms are mainly cyclic. They are nonribosomal peptides (NRPs) synthesized by huge protein complexes called nonribosomal peptide synthetases (NRPSs), and NRPs contain a high proportion of cyclic or branched nonproteogenic amino acids. Most of these cyclopeptides have biological and pharmacological properties, such as antibiotic and antitumor activities [99].
Bacillus pumilus strain KMM 1364, which is associated with Halocynthia aurantium, produced surfactin-like cyclic depsipeptides 1 (52), 2 (53), 6 (54), 7 (55) and 8 (56). These peptides, isolated as two C-terminal variants, have a leucine residue in position 4, in contrast to the valine present in the lipopeptide surfactin; the lipophilic parts of the peptide have not been completely characterized [33].
Didemnins A, B, and C, a class of cyclic depsipeptides, were first isolated from the Caribbean ascidian Trididemnum solidum in 1981 [17]. These compounds showed significant in vitrocytotoxicity and in vivoantitumor activity [18], and were also active against both DNA and RNA viruses [100]. Didemnin B (57) was the first marine compound to enter clinical trials as an antineoplastic agent, and exhibited anticancer activity in phase II clinical trials; however, it ultimately failed as a drug, because of its significant toxicity. Didemnin B now was confirmed to be produced by the marine α-proteobacteria Tistrella mobilis [18,19]. Complete genome sequence analysis of the T. mobilis strain KA081020-065 discovered the didemnin biosynthetic gene clusters; this lead to the hypothesis that didemnin X and Y precursors may be converted to didemnin B in this organism, which is an unusual post-synthetase activation mechanism [19].
Five new lipopeptide peptidolipins B–F (58–62) were isolated from the actinobacteria Nocardia sp., which is associated with Trididemnum orbiculatum. Peptidolipins B and E showed antimicrobial activities against methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-sensitive Staphylococcus aureus (MSSA) [51]. JBIR-66 (63), a new compound isolated from Saccharopolyspora sp. strain SS081219 JE-28 (associated with an unidentified ascidian) displayed relatively weak activity against human lymphoblastoid Namalwa cells. The structure of JBIR-66 was identified as (3Z,6E,8E)-N-(4-acetamido-3-hydroxybutyl)-2-hydroxy-4,8-dimethylundeca-3,6,8-trienamide on the basis of extensive NMR and MS spectroscopic data [54]. A new compound talarolide A (64) was isolated from Talaromyces sp. associated with ascidian, and reported to have no antifungal ability [85].
The patellamides are cyclic peptides that exemplify both the unique structural features and potent bioactivities of natural products isolated from ascidians of the Didemnidae family [64]. For example, in 1982 Lissoclinum patella was reported to produce cyclic peptide patellamides A–C, all of which contained an unusual fused oxazoline-thiazole unit. Subsequently patellamide D (1993), patellamide E (1992) and patellamide F (1995) were also isolated from L. patella. Patellamides A–C have cytotoxic activity against L1210 murine leukaemia cells, whereas patellamide D is a selective resistance-modifying agent [101,102,103,104]. Cyanobacteria of the genus Prochloron are obligate symbionts of many didemnid ascidians, and have been identified as the real producers of cyclic peptides of the patellamide class. For example, genetic evidence has shown that Prochloron didemni (associated with Lissoclinum patella, Republic of Palau) is the source of cytotoxic compounds patellamide A (65) and C (66) [64,68]. The patellamide biosynthesis gene from Prochloron sp. (associated with Lissoclinum patella, Great Barrier Reef, Australia) has been expressed in Escherichia coli, leading to the production of patellamide D (67) and ascidiacyclamide (68); both of these molecules are highly cytotoxic [66].
Trichoderma virens, a fungus isolated from Didemnum molle, produces two modified dipeptide trichodermamides, A (69) and B (70). The trichodermamides possess a rare cyclic O-alkyl-oxime functionality incorporated into a six-membered ring. Trichodermamide B displayed cytotoxicity against HCT-116 and antimicrobial activity against amphoterocin resistant Candida albicans, methacillin resistant Staphylococcus aureus and vancomycin resistant Enterococcus faecium [86]. Depsipeptide JBIR-113 (71) was isolated from the fungus Meyerozyma sp., which is associated with the ascidian Ciona intestinalis in China. This compound was reported to have lethality against brine shrimp Artemia salina [77]. This compound was previously isolated from a marine sponge-derived Penicillium sp. This compound was previously isolated from a marine sponge-derived Penicillium sp. fS36 in Japan, together with JBIR-114 and JBIR-115. These peptides are all of marine origin and contain pipecolic acid, which is very rarely found in natural products [105].

3.4. Alkaloids

Alkaloids are structurally diverse compounds generally classified as such, due to the basic character of the molecule, and the presence of at least one nitrogen atom, preferably in a heterocycle [106]. Alkaloids have been isolated from diverse natural organisms, including ascidians and microorganisms.
Sesbanimides A–C were previously isolated from the seeds of the leguminous plant Sesbania drummondii [107,108]. Later, sesbanimide A (72) was isolated from the bacteria Agrobacterium PH-130, which is associated with Ecteinascidia turbinata from the Florida peninsula, and sesbanimide C (73) was isolated from the bacteria Agrobacterium PH-A034C (associated with Polycitonidae sp.) along the Turkish coast [31]. Sesbanimide A is one of the most active sesbania alkaloids, with excellent in vitro cytotoxicity against KB cellsand potent in vivo activity against P-388 murine leukaemia [109]. Isolated from bacteria LL-14I352 (associated with an unidentified orange ascidian, Pacific Ocean, Fiji), phenazine compounds LL-14I352 α (or pelagiomicin) (74) and β (75) have diverse properties, such as antimicrobial activity, and the ability to inhibit DNA, RNA and protein synthesis, DNA-damaging activity; and cytotoxic activity [44]. 6-bromoindole-3-carbaldehyde (76) and its debromo analogue indole-3-carbaldehyde (77) were isolated from Acinetobacter sp. (associated with Stomozoa murrayi). Both compounds inhibit the settlement of cyprid larvae from the barnacle, Balanus amphitrite. Compound 76 also presented antimicrobial activity against strain SM-S2, strain SM-Z, Bacillus marinus and Vibrio campbellii [12]. In 1990, the structures of six newly isolated bioactive compounds (ecteinascidins 729, 743, 745, 759A, 759B, and 770) were assigned. The most abundant compound ET-743 showed excellentin vitro cytotoxicity against L1210 leukaemia cells and potentin vivoactivity against P388 murine leukaemia [15]. However, its clinical utility was hampered by inefficient methodologies for isolation of the compound. This led to the development of (semi)-synthetic methods for its large-scale production, which resulted in a novel anticancer agent sold under the brand name Yondelis (Trabectedin) [110]. Trabectedin is the first marine-derived anticancer drug to be approved by the European Union (2007), and is currently approved in more than 70 countries for the treatment of soft tissue sarcoma [111]. In recent years, using metagenomic sequencing of total DNA from the ascidian/microbial consortium, the natural source of ET-743/Yondelis (78) was determined to be the bacteria, Candidatus Endoecteinascidia frumentensis, which is associated with Ecteinascidia turbinate [16].
Indolocarbazole alkaloids, which are staurosporine derivatives, have received great attention as potent inhibitors of phospholipid/Ca2+ dependent protein kinase (protein kinase C) [112]. Staurosporine (79) was previously isolated from Eudistoma toealensis [113]. However, 16S rRNA tag pyrosequencing of the overall bacterial community suggested that two known bacterial producers of staurosporines, Salinispora sp. and Verrucosispora sp., were abundant in ascidian tissue, suggesting that the staurosporines were of microbial origin [57]. Two new piericidin compounds, C7 (80) and C8 (81), together with previously identified piericidins A1 (82) and A2 (83), were isolated from the actinobacteria Streptomyces sp. YM14-060, which in turn is associated with an unidentified greenish ascidian found in Iwayama Bay, Palau [114]. All of these four compounds showed cytotoxicity against RG-E1A-7 rat glial cells, and also inhibited the growth of Neuro-2a mouse neuroblastoma cells [114]. Compound 1,6-dihydroxyphenazine (84) was isolated from Nocardiopsis dassonvillei HQA404, which is associated with Botryllus schlosseri. This phenazine has antimicrobial activity against Vibrio anguillarum and Vibrio parahaemolyticus, lethal activity against Artemia salina, and enzyme inhibiting activity against Alpha-glucosidase [53]. Bohemamine (85) was isolated from Streptomyces sp., a bacterial associated with an unidentified ascidian collected from Lyttelton Harbor, New Zealand [115]. Four known diketopiperazine alkaloids, cyclo (6-OH-d-Pro-l-Phe) (86), bacillusamide B (87), cyclo (l-Pro-l-Leu) (88) and cyclo (l-Pro-l-Ile) (89), were isolated from actinobacteria Streptomyces sp. Did-27, which is associated with the Didemnum sp. These compounds exhibited cytotoxic activities against cancer cell lines HCT-116, HepG2 and MCF-7 [62]. Three new 2(1H)-pyrazinone derivatives, including (S)-6-(sec-butyl)-3-isopropylpyrazin-2(1H)-one (90), (S)-3-(sec-butyl)-6-isopropylpyrazin-2(1H)-one (91) and (S)-6-(sec-butyl)-3-isobutylpyrazin-2(1H)-one (92), together with the known (1H)-pyrazinones analogues deoxymutaaspergillic acid (93), 3,6-diisobutyl-2(1H)-pyrazinone (94) and 3,6-disec-butyl-2(1H)-pyrazinone (95) were isolated from the actinobacteria Streptomyces sp., which is associated with Didemnum sp. Expect for compound 91, all the other compounds presented cytotoxic activities against cancer cell lines HCT-116, HepG2 and MCF-7 [62].
Two new fumiquinazolines H (96) and I (97) have been isolated from the extracts of fungus Acremonium sp., which is associated with Ecteinascidia turbinate; they showed weak antimicrobial activity against Candida albicans [72]. A new benzopyran compound, 3,7-dimethyl-1,8-dihydroxy-6-methoxyisochroman (98) and a known mycotoxin 3,7-dimethyl-8-hydroxy-6-methoxyisochroman (99) have been isolated from Penicillium steckii, a fungus associated with an unidentified ascidian [78].

3.5. Other Types of Compounds Isolated from Ascidian-Associated Microorganisms

Steroids are compounds containing a four-ring structure termed the cyclopentanoperhydrophenanthrene nucleus. Two new cholic acid derivatives named 3,3,12-trihydroxy-7-ketocholanic acid (100) and 3,3,12-trihydroxy-7-deoxycholanic acid (101) were isolated from Hasllibacter halocynthiae strain KME 002T, which is associated with Halocynthia roretzi [36]. Another four cholic acid derivatives, 3α,12α-dihydroxy-7-ketocholanic acid (102), 12-hydroxy-3-keto-glycocholanic acid (103), nutriacholic acid (104) and deoxycholic acid (105) are also produced by H. halocynthiae [37]. Cholic acid is predominantly found in the bile of mammals and, as of 2012, has been identified in 11 bacterial strains. Furthermore, strain KME 002T was identified as the first nutriacholic acid-producing bacterium [37]. The marine bacterium Aeromicrobium halocynthiae KME 001T, which has been isolated from Halocynthia roretzi (Gangneung, Korea), produces the natural compound taurocholic acid (106) [48].
A mixture of 1(3),2-di-O-acyl-3(I)-O-β-gentiobiosylglycerols (107–119) were isolated from Bacillus pumilus associated with Halocynthia aurantium. The predominant component contains two C15 acyl groups, while the second component contains C15 and C17 fatty acids. Six minor components differ in the number and/or compositions of fatty acids [32].
Two new isocoumarin derivatives, stoloniferols A (120) and B (121), together with a known sterol, 5α,8α-epidioxy-23-methyl-(22E,24R)-ergosta-6,22-dien-3β-ol (122) were isolated from the fungus Penicillium stoloniferum QY2-10, which is associated with an unidentified ascidian. In vitro cytotoxicity assays revealed that 122 was selectively cytotoxic to the P388 cell line when compared to a panel of cancer cells. This is the first report of the cytotoxic activity of 122 [79]. Isocoumarins mellein (123), cis-4-hydroxymellein (124), trans-4-hydroxymellein (125), and penicillic acid (126) were isolated from the fungus Aspergillus sp., which is associated with Eudistoma vannamei. Only penicillic acid showed cytotoxicity against the tumor cell lines MDA-MB 435 and HCT-8 [75].
Two novel trialkyl-substituted aromatic acids, solwaric acid A (127) and solwaric acid B (128), were isolated from Sowaraspora sp., which is associated with Trididemnum orbiculatum; they showed antimicrobial activity against MRSA and MSSA [58]. 2-(acetylamino)-phenol (129) was isolated from Nocardiopsis dassonvillei strain HQA404, which is associated with Botryllus schlosseri., and it showed lethality against brine shrimp Artemia salina [53]. Two new carboxylic acids, tanzawic acids E and F (130,131) were produced by Penicillium steckii associated with an unidentified ascidian [78]. A new biphenyl ether derivative 2-hydroxy-6-(2′-hydroxy-3′-hydroxymethyl-5-methylphenoxy)-benzoic acid (132) was isolated from Indonesian ascidian-associated Talaromyces albobiverticillius (basionym: Penicillium albobiverticillium) TPU1432, and exhibited moderate inhibitory activities against protein tyrosine phosphatase (PTP) 1B, T cell PTP (TCPTP), and CD45 tyrosine phosphatase (CD45) [82]. β-nitro-propionic acid (133) was isolated from Humicola fuscoatra, which is associated with an unidentified ascidian; the compound showed antimicrobial activity against Staphylococcus aureus, Bacillus subtilis, Candida albicans and Escherichia coli [76].
The actinobacteria Solwaraspora sp., which is associated with Trididemnum orbiculatum (Florida Keys) produces 2,4,6-triphenyl-1-hexene (134), but this compound has no antimicrobial activity [58]. Three new oxepin-containing natural products, oxepinamides A–C (135–137) were isolated from Acremonium sp., which is associated with the Caribbean ascidian Ectcinascidia turbinata; oxepinamide A showed good anti-inflammatory activity in a topical RTX-induced mouse ear oedema assay [72].
Streptomyces sp. JP90, which was isolated from Aplidium lenticulum (Great Barrier Reef, Australia), produces a new organophosphate (S)-cinnamoylphosphoramide (138) that displayed inhibitory activity towards BChE [61].
Streptomyces sp. isolated from an unidentified ascidian (Lyttelton Harbor, New Zealand) was found to produce a new compound, S-methyl-2,4-dihydroxy-6-isopropyl-3,5-dimethylbenzothioate (139). This compound is only the fourth natural product reported to contain the S-methyl benzothioate group [115]. Macrolactins E (140) and F (141), together with gilvocarcins M (142) and V (143) have been isolated from an unidentified ascidian-associated actinobacteria Saccharopolyspora sp. SS081219 JE-28 [54].
Aspergillus candidus KMM 4676, which was isolated from an unidentified colonial ascidian, produces terphenyllin (144), 4″-dehydroxy-3′-hydroxyterphenyllin (145), 3′-hydroxyterphenyllin (146), candidusin A (147), 4″-dehydroxycandidusin A (148) and chlorflavonin (149). Furthermore, compound 147 and 148 showed cytotoxicity against hormone-sensitive prostate cancer cell line LNCaP [73].
The known diterpene glycoside sordarin (150) was produced by Talaromyces sp. CMB TU011 isolated from an unidentified ascidian, and it presented antifungal activity [85].

3.6. Summary of Natural Products

150 natural products have been isolated from microorganisms associated with ascidians up to 2017. Natural products originating from ascidian-associated microorganisms is a hot research topic, as evidenced by the surge of publications in this area beginning in the 2000 (Figure 3). Among them, polyketides and alkaloid compounds represent 43.3% of the total number (Figure 4). Most of these compounds have potent bioactivities, and induce in vitro cytotoxicity, or have antimicrobial, anti-inflammatory, antioxidant, and antifouling properties, to name only a few properties (Figure 5). Some compounds have in vivo antitumor activity, and several promising drugs have been used in preclinical evaluation and clinical trials. How far have we progressed in the understanding of the molecular mechanisms of action of these compounds?
Microorganisms are a promising source of bioactive compounds, and the discovery of new strains is vital for new or more active compounds [116]. As discussed in this review, most compounds have been isolated from bacteria, cyanobacteria, actinobacteria, and fungi associated with ascidians (Figure 6). Some compounds were initially considered to be from ascidians, but later confirmed to be produced by ascidian-associated bacteria, such as the well-known ET-743 and Didemnin B; others were isolated directly from the symbiotic microorganisms [32]. Because of the large number of compounds isolated from ascidians, approximately 1080 in 2012 [117], it is important to confirm the true source of more compounds. We think that only the tip of the iceberg has been explored in this regard.

4. Conclusions

The marine environment supplies many kinds of habitats that support marine life. It provides an extremely distinct environment for its living organisms. The diverse conditions enable high microbial diversity, and this in turn is associated with biological elaboration of more novel chemical structures [118]. This review has presented 150 natural products produced by ascidian-associated microorganisms. These secondary metabolites belong to polyketides, terpenoids, peptides, alkaloids and other types, and showed a good range of bioactivities. These results indicates the potential of the microorganisms associated with ascidians as sources of bioactive natural products.
In recent years, new approaches to the isolation of microorganisms have been greatly improved. High-throughput cultivation of microorganisms using microcapsules provides an approach to cultivate more biomass. Flow cytometry can then be used to select the microcapsules containing microcolonies. This method can obtain more than 10,000 bacterial and fungal isolates per environmental sample [119]. In 2009, microorganism samples from the coral mucus were encapsulated within agar spheres, encased in a polysulphonic polymeric membrane, and incubated on the mucus surface of coral Fungia granulosa. Massive microorganisms obtained shared only 50% similarity (85–96%) with previously identified microorganisms [120]. Alternatively, diffusion growth chambers (DGCs) provide another approach to isolate ‘uncultivable’ microorganisms, as they can be implanted in the tissue of the organism of choice. In 2014, DGCs were first utilized for the cultivation of marine sponge-associated bacteria. Two hundred and fifty-five 16S rRNA gene sequences were obtained, among which 15 sequences were from previously undescribed bacteria [121]. The successful application of new, effective, and efficient approaches in isolating microorganisms will surely contribute to the discovery of novel natural products. However, there are few reports on isolating approaches for ascidian-associated microorganisms. Ongoing studies in our laboratory have been designed to accelerate the isolation of new microorganisms and novel compounds from ascidians.
In closing, we note that with further biotechnological advances, new methods in chemical and biological synthesis will contribute to the discovery of novel and complex drug leads. During the process of finding new compounds, researchers are now sufficiently empowered by such advances that they can think creatively about the drug discovery process. Once the microorganism biosynthetic gene clusters and chemical synthetic routes have been characterized, they can be cloned, artificially modified, and expressed in order to efficiently produce larger amounts of specific compounds, or structurally novel chemical tools [122].

Author Contributions

L.C., C.-L.S. and G.-Y.W. conceived and designed the format of the manuscript. L.C. and J.-S.H. analysed the data, drafted and edited the manuscript. J.-S.H. and J.-L.X. drew the chemical structure of compounds. C.-L.S. and G.-Y.W. reviewed the manuscript. All the authors contributed in terms of critical reading and discussion of the manuscript.

Funding

This study was funded by the National Natural Science Foundation of China (No. 31300009), Natural Scientific Research Innovation Foundation in Harbin Institute of Technology (No. HIT. NSRIF. 2014127) and Discipline Construction Guide Foundation in Harbin Institute of Technology at Weihai (No. WH20150204 and No. WH20160205).

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Ascidiacea World Database. Available online: www.marinespecies.org/ascidiacea (accessed on 11 February 2017).
  2. Davidson, B.S. Ascidians: Producers of amino acid-derived metabolites. Chem. Rev. 1993, 93, 1771–1791. [Google Scholar] [CrossRef]
  3. Chen, L.; Fu, C.M.; Wang, G.Y. Microbial diversity associated with ascidians: A review of research methods and application. Symbiosis 2017, 71, 19–26. [Google Scholar] [CrossRef]
  4. Fermé, C.; Mateos, M.V.; Szyldergemajn, S.; Corrado, S.C.; Zucca, E.; Extremera, S.; Gianni, A.M.; Vandermeeren, A.; Ribrag, V. Aplidin® (Plitidepsin) activity in peripheral T-cell lymphoma (PTCL): Final results. Blood 2010, 116, 1767. [Google Scholar]
  5. Stone, R.M.; Mandrekar, S.; Sanford, B.L.; Geyer, S.; Bloomfield, C.D.; Dohner, K.; Thiede, C.; Marcucci, G.; Lo-Coco, F.; Klisovic, R.B.; et al. The multi-kinase inhibitor midostaurin (M) prolongs survival compared with placebo (P) in combination with daunorubicin (D)/cytarabine (C) induction (ind), high-dose C consolidation (consol), and as maintenance (maint) therapy in newly diagnosed acute myeloid leukemia (AML) patients (pts) age 18–60 with FLT3 mutations (muts): An international prospective randomized (rand) P-controlled double-blind trial (CALGB 10603/RATIFY [Alliance]). In Proceedings of the American Society of Hematology (ASH) 57th Annual Meeting, Orlando, FL, USA, 5–8 December 2005. [Google Scholar]
  6. Levis, M.; Ravandi, F.; Wang, E.S.; Baer, M.R.; Perl, A.; Coutre, S.; Erba, H.; Stuart, R.K.; Baccarani, M.; Cripe, L.D.; et al. Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse. Blood 2011, 117, 3294–3301. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  7. Saif, M.W.; Diasio, R.B. Edotecarin: A novel topoisomerase I inhibitor. Clin. Colorectal Cancer 2005, 5, 27–36. [Google Scholar] [CrossRef] [PubMed]
  8. Li, Z.Y. Advances in marine microbial symbionts in the China Sea and related pharmaceutical metabolites. Mar. Drugs 2009, 7, 113–129. [Google Scholar] [CrossRef] [PubMed]
  9. Schmidt, E.W.; Donia, M.S. Life in cellulose houses: Symbiotic bacterial biosynthesis of ascidian drugs and drug leads. Curr. Opin. Biotechnol. 2010, 21, 827–833. [Google Scholar] [CrossRef] [PubMed]
  10. Lars, S.; Kjeldsen, K.U.; Funch, P.; Jensen, J.; Obst, M.; López-Legentil, S.; Schramm, A. Endozoicomonas are specific, facultative symbionts of sea squirts. Front. Microbiol. 2016, 7, 1042. [Google Scholar] [CrossRef]
  11. Das, S.; Lyla, P.S.; Khan, S.A. Marine microbial diversity and ecology: Importance and future perspectives. Curr. Sci. 2006, 90, 1325–1335. [Google Scholar]
  12. Olguin-Uribe, G.; Abou-Mansour, E.; Boulander, A.; Débard, H.; Francisco, C.; Combaut, G. 6-bromoindole-3-carbaldehyde, from an Acinetobacter sp. bacterium associated with the ascidian Stomozoa murrayi. J. Chem. Ecol. 1997, 23, 2507–2521. [Google Scholar] [CrossRef]
  13. Socha, A.M.; Garcia, D.; Sheffer, R.; Rowley, D.C. Antibiotic bisanthraquinones produced by a Streptomycete isolated from a cyanobacterium associated with Ecteinascidia turbinata. J. Nat. Prod. 2006, 69, 1070–1073. [Google Scholar] [CrossRef] [PubMed]
  14. Asolkar, R.N.; Kirkland, T.N.; Jensen, P.R.; Fenical, W. Arenimycin, an antibiotic effective against rifampin- and methicillin-resistant Staphylococcus aureus from the marine actinomycete Salinispora arenicola. J. Antibiot. (Tokyo) 2010, 63, 37–39. [Google Scholar] [CrossRef] [PubMed]
  15. Rinehart, K.L.; Holt, T.G.; Fregeau, N.L.; Stroh, J.G.; Keifer, P.A.; Sun, F.; Li, L.H.; Martin, D.G. Ecteinascidins 729, 743, 745, 759A, 759B, and 770: Potent antitumor agents from the Caribbean tunicate Ecteinascidia turbinata. J. Org. Chem. 1990, 55, 4512–4515. [Google Scholar] [CrossRef]
  16. Rath, C.M.; Janto, B.; Earl, J.; Ahmed, A.; Hu, F.Z.; Hiller, L.; Dahlgren, M.; Kreft, R.; Yu, F.; Wolff, J.J.; et al. Metaomic characterization of the marine invertebrate microbial consortium that produces the chemotherapeutic natural product ET-743. ACS Chem. Biol. 2011, 6, 1244–1256. [Google Scholar] [CrossRef] [PubMed]
  17. Rinehart, K.L.; Gloer, J.B.; Hughes, R.G.; Renis, H.E.; Mcgovern, J.P.; Swynenberg, E.B.; Stringfellow, D.A.; Kuentzel, S.L.; Li, L.H. Didemnins: Antiviral and antitumor depsipeptides from a Caribbean tunicate. Science 1981, 212, 933–935. [Google Scholar] [CrossRef] [PubMed]
  18. Tsukimoto, M.; Nagaoka, N.; Shishido, Y.; Fujimoto, J.; Nishisaka, F.; Matsumoto, S.; Harunari, E.; Imada, C.; Matsuzaki, T. Bacterial production of the tunicate-derived antitumor cyclic depsipeptide Didemnin B. J. Nat. Prod. 2011, 74, 2329–2331. [Google Scholar] [CrossRef] [PubMed]
  19. Xu, Y.; Kersten, R.D.; Nam, S.G.; Lu, L.; Al-Suwailem, A.M.; Zheng, H.; Fenical, W.; Dorrestein, P.C.; Moore, B.S.; Qian, P.Y. Bacterial biosynthesis and maturation of the didemnin anti-cancer agents. J. Am. Chem. Soc. 2012, 134, 8625–8632. [Google Scholar] [CrossRef] [PubMed]
  20. Schmidt, E.W. The secret to a successful relationship: Lasting chemistry between ascidians and their symbiotic bacteria. Invertebr. Biol. 2014, 134, 88–102. [Google Scholar] [CrossRef] [PubMed]
  21. Tianero, M.D.; Kwan, J.C.; Wyche, T.P.; Presson, A.P.; Koch, M.; Barrows, L.R.; Bugni, T.S.; Schmidt, E.W. Species specificity of symbiosis and secondary metabolism in ascidians. ISME J. 2015, 9, 615–628. [Google Scholar] [CrossRef] [PubMed]
  22. Tait, E.; Sievert, C.S.M. Phylogenetic diversity of bacteria associated with ascidians in Eel Pond (Woods Hole, Massachusetts, USA). J. Exp. Mar. Biol. Ecol. 2007, 342, 138–146. [Google Scholar] [CrossRef]
  23. Abdelmohsen, U.R.; Bayer, K.; Hentschel, U. Diversity, abundance and natural products of marine sponge-associated actinomycetes. Nat. Prod. Rep. 2014, 31, 381–399. [Google Scholar] [CrossRef] [PubMed]
  24. Chen, P.; Zhang, L.M.; Guo, X.X.; Dai, X.; Liu, L.; Wang, J.; Song, L.; Wang, Y.Z.; Zhu, Y.X.; Huang, L.; et al. Diversity, biogeography, and biodegradation potential of actinobacteria in the deep-sea sediments along the Southwest Indian Ridge. Front. Microbiol. 2016, 7, 1340. [Google Scholar] [CrossRef] [PubMed]
  25. Sarmientovizcaíno, A.; González, V.; Braña, A.F.; Palacios, J.J.; Otero, L.; Fernández, J.; Molina, A.; Kulik, A.; Vázquez, F.; Acuña, J.L.; et al. Pharmacological potential of phylogenetically diverse actinobacteria isolated from deep-sea coral ecosystems of the submarine aviles canyon in the Cantabrian Sea. Microbiol. Ecol. 2016, 73, 338–352. [Google Scholar] [CrossRef] [PubMed]
  26. Fang, J.; Kato, C.; Runko, G.M.; Nogi, Y.; Hori, T.; Li, J.T.; Morono, Y.; Inagaki, F. Predominance of viable spore-forming piezophilic bacteria in high-pressure enrichment cultures from ~1.5 to 2.4 km-deep coal-bearing sediments below theocean floor. Front. Microbiol. 2017, 8, 137. [Google Scholar] [CrossRef] [PubMed]
  27. Olson, R.R. Photoadaptations of the Caribbean colonial ascidian-cyanophyte symbiosis Trididemnum solidum. Biol. Bull. 1986, 170, 62–74. [Google Scholar] [CrossRef]
  28. Qu, W.Y.; Chen, L.; Wang, G.Y.; Yan, P.S. Symbiosis between ascidian and cyanobacteria. Microbiol. China 2017, 44, 458–464. (In Chinese) [Google Scholar]
  29. López-Legentil, S.; Erwin, P.M.; Turon, M.; Yarden, O. Diversity of fungi isolated from three temperate ascidians. Symbiosis 2015, 66, 99–106. [Google Scholar] [CrossRef]
  30. Menezes, C.B.; Bonugli-Santo, R.C.; Miqueletto, P.B.; Passarini, M.R.Z.; Sliva, C.H.D.; Justo, M.R.; Leal, R.R.; Fantinatti-Garbonggini, F.; Oliveira, V.M.; Berlinck, R.G.S.; et al. Microbial diversity associated with algae, ascidians and sponges from the north coast of São Paulo state, Brazil. Microbiol. Res. 2010, 165, 466–482. [Google Scholar] [CrossRef] [PubMed]
  31. Acebal, C.; Alcazar, R.; Cañedo, L.M.; De, L.C.F.; Rodriguez, P.; Romero, F.; Puentes, J.L.F. Two marine Agrobacterium producers of sesbanimide antibiotics. J. Antibiot. 1998, 51, 64–67. [Google Scholar] [CrossRef] [PubMed]
  32. Kalinovskaya, N.I.; Kuznetsova, T.A.; Kalinovsky, A.I.; Denisenka, V.A.; Svetashev, V.I.; Romanenko, L.A. Structural characterization of gentiobiosyl diglycerides from Bacillus pumilus assoicated with ascidian Haloccynthia aurantium. Russ. Chem. Bull. 2000, 49, 169–173. [Google Scholar] [CrossRef]
  33. Kalinovskaya, N.I.; Kuznetsova, T.A.; Ivanova, E.P.; Romanenko, L.A.; Voinov, V.G.; Huth, F.; Laatsch, H. Characterization of surfactin-like cyclic depsipeptides Bacillus pumilus from ascidian Halocynthia aurantium. Mar. Biotechnol. 2002, 4, 179–188. [Google Scholar] [CrossRef] [PubMed]
  34. Kwan, J.C.; Donia, M.S.; Han, A.W.; Hirose, E.; Haygood, M.G.; Schmidt, E.W. Genome streamlining and chemical defense in a coral reef symbiosis. Proc. Natl. Acad. Sci. USA 2012, 109, 20655–20660. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  35. Romanenko, L.A.; Schumann, P.; Rohde, M.; Mikhailov, V.V.; Stackebrandt, E. Halomonas halocynthiae sp. nov., isolated from the marine ascidian Halocynthia aurantium. Int. J. Syst. Evol. Microbiol. 2002, 52, 1767–1772. [Google Scholar] [CrossRef] [PubMed]
  36. Kim, S.H.; Shin, Y.K.; Sohn, Y.K.; Kwon, H.C. Two new cholic acid derivatives from the marine ascidian-associated bacterium Hasllibacter halocynthiae. Molecules 2012, 17, 12357–12364. [Google Scholar] [CrossRef] [PubMed]
  37. Kim, S.H.; Yang, H.O.; Shin, Y.K.; Kwon, H.C. Hasllibacter halocynthiae gen. nov., sp. nov., a nutriacholic acid-producing bacterium isolated from the marine ascidian Halocynthia roretzi. Int. J. Syst. Evol. Microbiol. 2012, 62, 624–631. [Google Scholar] [CrossRef] [PubMed]
  38. Lu, D.C.; Zhao, J.X.; Wang, F.Q.; Xie, Z.H.; Du, Z.J. Labilibacter aurantiacus gen. nov., sp. nov., isolated from sea squirt (Styela clava) and reclassification of Saccharicrinis marinus as Labilibacter marinus comb. nov. Int. J. Syst. Evol. Microbiol. 2017, 67, 441–446. [Google Scholar] [CrossRef] [PubMed]
  39. Romanenko, L.A.; Uchino, M.; Falsen, E.; Lysenko, A.M.; Zhukova, N.V.; Mikhailov, V.V. Pseudomonas xanthomarina sp. nov., a novel bacterium isolated from marine ascidian. J. Gen. Appl. Microbiol. 2005, 51, 65–71. [Google Scholar] [CrossRef] [PubMed]
  40. Yoon, J.; Matsuda, S.; Adachi, K.; Kasai, H.; Yokota, H. Rubritalea halochordaticola sp. nov., a carotenoid-producing verrucomicrobial species isolated from a marine chordate. Int. J. Syst. Evol. Microbiol. 2011, 61, 1515–1520. [Google Scholar] [CrossRef] [PubMed]
  41. Kim, Y.O.; Park, S.; Nam, B.H.; Kang, S.J.; Hur, Y.B.; Lee, S.J.; Oh, T.K.; Yoon, J.H. Ruegeria halocynthiae sp. nov., isolated from the sea squirt Halocynthia roretzi. Int. J. Syst. Evol. Microbiol. 2012, 62, 925–930. [Google Scholar] [CrossRef] [PubMed]
  42. Kim, Y.O.; Park, S.; Nam, B.H.; Jung, Y.T.; Kim, D.G.; Jee, Y.J.; Yoon, J.H. Tenacibaculum halocynthiae sp. nov., a member of the family Flavobacteriaceae isolated from sea squirt Halocynthia roretzi. Antonie Van Leeuwenhoek 2013, 103, 1321–1327. [Google Scholar] [CrossRef] [PubMed]
  43. Gnanakkan, A. Optimization of novel protease production through submerged fermetation by ascidian associated Vibrio. World J. Pharm. Pharm. Sci. 2014, 3, 765–770. [Google Scholar]
  44. Singh, M.P.; Menendez, A.T.; Petersen, P.J.; Ding, W.D.; Maiese, W.M.; Greenstein, M. Biological and mechanistic activities of phenazine antibiotics produced by culture LL-14I352. J. Antibiot. 1997, 50, 785–787. [Google Scholar] [CrossRef] [PubMed]
  45. Blasiak, L.C.; Zinder, S.H.; Buckley, D.H.; Hill, R.T. Bacterial diversity associated with the tunic of the model chordate Ciona intestinalis. ISME J. 2014, 8, 309–320. [Google Scholar] [CrossRef] [PubMed]
  46. Wyche, T.P.; Miranda, S.; Hou, Y.; Doug, B.; Johnson, D.A.; Johnson, J.A.; Bugni, T.S. Activation of the nuclear factor E2-related factor 2 pathway by novel natural products halomadurones A–D and a synthetic analogue. Mar. Drugs 2013, 11, 5089–5099. [Google Scholar] [CrossRef] [PubMed]
  47. Wyche, T.P.; Alvarenga, R.F.R.; Piotrowski, J.S.; Duster, M.N.; Warrack, S.R.; Cornilescu, G.; De Wolfe, T.J.; Hou, Y.; Braun, D.R.; Ellis, G.A.; et al. Chemical genomics, structure elucidation, and in vivo studies of the marine-derived Anticlostridial Ecteinamycin. ACS Chem. Biol. 2017, 12, 2287–2295. [Google Scholar] [CrossRef] [PubMed]
  48. Kim, S.H.; Yang, H.O.; Sohn, Y.C.; Kwon, H.C. Aeromicrobium halocynthiae sp. nov., a taurocholic acid-producing bacterium isolated from the marine ascidian Halocynthia roretzi. Int. J. Syst. Evol. Microbiol. 2010, 60, 2793–2798. [Google Scholar] [CrossRef] [PubMed]
  49. De Menezes, C.B.A.; Afonso, R.S.; de Souza, W.R.; Parma, M.; de Melo, I.S.; Zucchi, T.D.; Garboggini, F.F. Gordonia didemni sp. nov. an actinomycete isolated from the marine ascidium Didemnum sp. Antonie Van Leeuwenhoek 2016, 109, 297–303. [Google Scholar] [CrossRef] [PubMed]
  50. Jimenez, P.C.; Ferreira, E.G.; Araújo, L.A.; Guimarães, L.A.; Sousa, T.S.; Pessoa, O.D.L.; Lotufo, T.M.C.; Costa-Lotufo, L.V. Cytotoxicity of actinomycetes associated with the ascidian Eudistoma vannamei (Millar, 1977), endemic of northeastern coast of Brazil. Lat. Am. J. Aquat. Res. 2013, 41, 335–343. [Google Scholar] [CrossRef]
  51. Wyche, T.P.; Hou, Y.; Vazquez-Rivera, E.; Braun, D.; Bugni, T.S. Peptidolipins B–F, antibacterial lipopeptides from an ascidian-derived Nocardia sp. J. Nat. Prod. 2012, 75, 735–740. [Google Scholar] [CrossRef] [PubMed]
  52. Kuznetsova, T.A.; Dmitrenok, A.S.; Sobolevskaya, M.P.; Shevchenko, L.S.; Mikhailov, V.V. Ubiquinone Q9 from a marine isolate of an actinobacterium Nocardia sp. Russ. Chem. Bull. 2002, 51, 1951–1953. [Google Scholar] [CrossRef]
  53. Pei, Z.L.; Chen, L.; Xu, J.L.; Shao, C.L. Secondary metabiolities and their biological activities of two actinomycetes Streptomyces coelicoflavus and Nocardiopsis dassonvillei associated with ascidians Styela clava and Botryllus schlosseri. Chin. J. Mar. Drugs 2017, 36, 55–60. [Google Scholar]
  54. Takagi, M.; Motohashi, K.; Izumikawa, M.; Khan, S.T.; Hwang, J.H.; Shin-Ya, K. JBIR-66 a new metabolite isolated from tunicate-derived Saccharopolyspora sp. Biosci. Biotechnol. Biochem. 2010, 74, 2355–2357. [Google Scholar] [CrossRef] [PubMed]
  55. He, H.; Ding, W.D.; Bernan, V.S.; Richardson, A.D.; Ireland, C.M.; Greenstein, M.; Ellestad, G.A.; Carter, G.T. Lomaiviticins A and B, potent antitumor antibiotics from Micromonospora lomaivitiensis. J. Am. Chem. Soc. 2001, 123, 5362–5363. [Google Scholar] [CrossRef] [PubMed]
  56. Janso, J.E.; Haltli, B.A.; Eustáquio, A.S.; Kulowski, K.; Waldman, A.J.; Zha, L.; Nakamura, H.; Bernan, V.S.; He, H.; Carter, G.T.; et al. Discovery of the lomaiviticin biosynthetic gene cluster in Salinispora pacifica. Tetrahedron 2014, 70, 4156–4164. [Google Scholar] [CrossRef] [PubMed]
  57. Steinert, G.; Taylor, M.W.; Schupp, P.J. Diversity of actinobacteria associated with the marine ascidian Eudistoma toealensis. Mar. Biotechnol. 2015, 17, 377–385. [Google Scholar] [CrossRef] [PubMed]
  58. Ellis, G.A.; Wyche, T.P.; Fry, C.G.; Braun, D.R.; Bugni, T.S. Solwaric acids A and B, antibacterial aromatic acids from a marine Solwaraspora sp. Mar. Drugs 2014, 12, 1013–1022. [Google Scholar] [CrossRef] [PubMed]
  59. Harunari, E.; Hamada, M.; Shibata, C.; Tamura, T.; Komaki, H.; Imada, C.; Igarashi, Y. Streptomyces hyaluromycini sp. nov., isolated from a tunicate (Molgula manhattensis). J. Antibiot. 2015, 69, 159–163. [Google Scholar] [CrossRef] [PubMed]
  60. Li, A.; Piel, J. A gene cluster from a marine Streptomyces encoding the biosynthesis of the aromatic spiroketal polyketide griseorhodin A. Chem. Biol. 2002, 9, 1017–1026. [Google Scholar] [CrossRef]
  61. Melanie, Q.; Tim, S.; Jörn, P.; Paultheo, V.Z.; Stephanie, G. The new metabolite (S)-cinnamoylphosphoramide from Streptomyces sp. and its total synthesis. Eur. J. Org. Chem. 2008, 2008, 5117–5124. [Google Scholar] [CrossRef]
  62. Shaala, L.A.; Youssef, D.T.A.; Badr, J.M.; Harakeh, S.M. Bioactive 2 (1H)-pyrazinones and diketopiperazine alkaloids from a tunicate-derived actinomycete Streptomyces sp. Molecules 2016, 21, 1116. [Google Scholar] [CrossRef] [PubMed]
  63. Sung, A.A.; Gromek, S.M.; Balunas, M.J. Upregulation and identification of antibiotic activity of a marine-derived Streptomyces sp. via co-cultures with human pathogens. Mar. Drugs 2017, 15, 250. [Google Scholar] [CrossRef] [PubMed]
  64. Schmidt, E.W.; Nelson, J.T.; Rasko, D.A.; Sudek, S.; Eisen, J.A.; Haygood, M.G.; Ravel, J. Patellamide A and C biosynthesis by a microcin-like pathway in Prochloron didemni, the cyanobacterial symbiont of Lissoclinum patella. Proc. Natl. Acad. Sci. USA 2005, 102, 7315–7320. [Google Scholar] [CrossRef] [PubMed]
  65. Kott, P. Didemnid-algal symbiosis: Host species in the Western Pacific with notes on the symbiosis. Micronesica 1982, 18, 95–127. [Google Scholar]
  66. Long, P.F.; Dunlap, W.C.; Battershill, C.N.; Jaspars, M. Shotgun cloning and heterologous expression of the patellamide gene cluster as a strategy to achieving sustained metabolite production. Chembiochem 2005, 6, 1760–1765. [Google Scholar] [CrossRef] [PubMed]
  67. Hirose, E.; Turon, X.; López-Legentil, S.; Erwin, P.M.; Hirose, M. First records of didemnid ascidians harbouring Prochloron from Caribbean Panama: Genetic relationships between Caribbean and Pacific photosymbionts and host ascidians. Syst. Biodivers. 2012, 10, 435–445. [Google Scholar] [CrossRef]
  68. Schmidt, E.W.; Sudek, S.; Haygood, M.G. Genetic evidence supports secondary metabolic diversity in Prochloron spp. the cyanobacterial symbiont of a tropical ascidian. J. Nat. Prod. 2004, 67, 1341–1345. [Google Scholar] [CrossRef] [PubMed]
  69. Lewin, R.A. A marine Synechocystis (Cyanophyta, Chroococcales) epizoic on ascidians. Phycologia 1975, 14, 153–160. [Google Scholar] [CrossRef]
  70. Kott, P. Algal-bearing didemnid ascidians in the Indo-West Pacific. Mem. Qd Mus. 1980, 20, 1–47. [Google Scholar]
  71. Hirose, E.; Uchida, H.; Murakami, A. Ultrastructural and microspectrophotometric characterization of multiple species of cyanobacterial photosymbionts coexisting in the colonial ascidian Trididemnum clinides (Tunicata, Ascidiacea, Didemnidae). Eur. J. Phycol. 2009, 44, 365–375. [Google Scholar] [CrossRef]
  72. Belofsky, G.N.; Anguera, M.; Jensen, P.R.; Fenical, W.; Kock, M. Oxepinamides A–C and fumiquinazolines H–I: Bioactive metabolites from a marine isolate of a fungus of the genus Acremonium. Chem. Eur. J. 2000, 6, 1355–1360. [Google Scholar] [CrossRef]
  73. Yurchenko, A.N.; Ivanets, E.V.; Smetanina, O.F.; Pivkin, M.V.; Dyshlovoi, S.A.; Amsberg, G.V.; Afiyatullov, S.S. Metabolites of the marine fungus Aspergillus candidus KMM 4676 associated with a Kuril colonial ascidian. Chem. Nat. Compd. 2017, 53, 747–749. [Google Scholar] [CrossRef]
  74. Bugni, T.S.; Abbanat, D.; Bernan, V.S.; Maiese, W.M.; Greenstein, M.; Wagoner, R.M.A.; Ireland, C.M. Yanuthones: Novel metabolites from a marine isolate of Aspergillus niger. J. Org. Chem. 2000, 65, 7195–7200. [Google Scholar] [CrossRef] [PubMed]
  75. Montenegro, T.G.C.; Rodrigues, F.A.R.; Jimenez, P.C.; Angelim, A.L.; Melo, V.M.M.; Filho, E.R.; de Oliveira, M.C.F.; Costa-Lotufo, L.V. Cytotoxic activity of fungal strains isolated from the ascidian Eudistoma vannamei. Chem. Biodivers. 2012, 9, 2203–2209. [Google Scholar] [CrossRef] [PubMed]
  76. Smetanina, O.F.; Kuznetsova, T.A.; Gerasimenko, A.V.; Kalinovsky, A.I.; Pivkin, M.V.; Dmitrenok, P.C.; Elyakov, G.B. Metabolites of the marine fungus Humicola fuscoatra, KMM 4629. Russ. Chem. Bull. 2004, 36, 2643–2646. [Google Scholar] [CrossRef]
  77. Pei, Z.L. Secondary Metabiolities and Bioactivity of Three Microorganisms Associated with Ascidians. Master’s Thesis, Harbin Institute of Technology, Weihai, China, 2016. [Google Scholar]
  78. Malmstrùm, J.; Christophersen, C.; Frisvad, J.C. Secondary metabolites characteristic of Penicillium citrinum, Penicillium steckii and related species. Phytochemistry 2000, 54, 301–309. [Google Scholar] [CrossRef]
  79. Xin, Z.H.; Tian, L.; Zhu, T.J.; Wang, W.L.; Du, L.; Fang, Y.C.; Gu, Q.Q.; Zhu, W.M. Isocoumarin derivatives from the sea squirt-derived fungus Penicillium stoloniferum QY2-10 and the halotolerant fungus Penicillium notatum B-52. Arch. Pharm. Res. 2007, 30, 816–819. [Google Scholar] [CrossRef] [PubMed]
  80. Motohashi, K.; Hashimoto, J.; Inaba, S.; Khan, S.T.; Komaki, H.; Nagai, A.; Takagi, M.; Shin-Ya, K. New sesquiterpenes, JBIR-27 and -28, isolated from a tunicate-derived fungus, Penicillium sp. SS080624SCf1. J. Antibiot. 2009, 62, 247–250. [Google Scholar] [CrossRef] [PubMed]
  81. Wang, G.Y.S.; Borgeson, B.M.; Crews, P. Pitholides A–D, polyketides from a marine tunicate-derived culture of Pithomyces sp. Tetrahedron Lett. 1997, 38, 8449–8452. [Google Scholar] [CrossRef]
  82. Sumilat, D.A.; Yamazaki, H.; Endo, K.; Rotinsulu, H.; Wewengkang, D.S.; Ukai, K.; Namikoshi, M. A new biphenyl ether derivative produced by Indonesian ascidian-derived Penicillium albobiverticillium. J. Nat. Med. 2017, 71, 776–779. [Google Scholar] [CrossRef] [PubMed]
  83. Samson, R.A.; Yilmaz, N.; Houbraken, J.; Spierenburg, H.; Seifert, K.A.; Peterson, S.W.; Varga, J.; Frisvad, J.C. Phylogeny and nomenclature of the genus Talaromyces and taxa accommodated in Penicillium subgenus Biverticillium. Stud. Mycol. 2011, 70, 159–183. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  84. Yamazaki, H.; Nakayama, W.; Takahashi, O.; Kirikoshi, R.; Izumikawa, Y.; Iwasaki, K.; Toraiwa, K.; Ukai, K.; Rotinsulu, H.; Wewengkang, D.S.; et al. Verruculides A and B, two new protein tyrosine phosphatase 1B inhibitors from an Indonesian ascidian-derived Penicillium verruculosum. Bioorg. Med. Chem. Lett. 2015, 25, 3087–3090. [Google Scholar] [CrossRef] [PubMed]
  85. Dewapriya, P.; Prasad, P.; Damodar, R.; Salim, A.A.; Capon, R.J. Talarolide A, a cyclic heptapeptide hydroxamate from an Australian marine tunicate-associated fungus, Talaromyces sp. (CMB-TU011). Org. Lett. 2017, 19, 2046–2049. [Google Scholar] [CrossRef] [PubMed]
  86. Garo, E.; Starks, C.M.; Jensen, P.R.; Fenical, W.; Lobkovsky, E.; Clardy, J. Trichodermamides A and B, cytotoxic modified dipeptides from the marine-derived fungus Trichoderma virens. J. Nat. Prod. 2003, 66, 423–426. [Google Scholar] [CrossRef] [PubMed]
  87. Lin, Z.J.; Koch, M.; Abdel, A.M.H.; Galindo-Murillo, R.; Tianero, M.D.; Cheatham, T.E.; Barrows, L.R.; Reilly, C.A.; Schmidt, E.W. Oxazinin A, a pseudodimeric natural product of mixed biosynthetic origin from a filamentous fungus. Org. Lett. 2014, 16, 4774–4777. [Google Scholar] [CrossRef] [PubMed]
  88. Shen, B. Polyketide biosynthesis beyond the type I, II and III polyketide synthase paradigms. Curr. Opin. Chem. Biol. 2003, 7, 285–295. [Google Scholar] [CrossRef]
  89. Riesenfeld, C.S.; Murray, A.E.; Baker, B.J. Characterization of the microbial community and polyketide biosynthetic potential in the palmerolide-producing tunicate Synoicum adareanum. J. Nat. Prod. 2008, 71, 1812–1818. [Google Scholar] [CrossRef] [PubMed]
  90. Diyabalanage, T.; Amsler, C.D.; McClintock, J.B.; Baker, B.J. Palmerolide A, a cytotoxic macrolide from the Antarctic tunicate Synoicum adareanum. J. Am. Chem. Soc. 2006, 128, 5630–5631. [Google Scholar] [CrossRef] [PubMed]
  91. Diyabalanage, T. Chemical Investigation of Two Antarctic Invertebrates, Synoicum adareanum (Chordata: Ascidiaceae; Enterogona; Polyclinidae) and Austrodoris kergulenensis (Molusca; Gastropoda; Nudibranchia; Dorididae). Ph.D. Thesis, University of South Florida, Tallahassee, FL, USA, 2006. [Google Scholar]
  92. Richardson, A.D.; Aalbersberg, W.; Ireland, C.M. The patellazoles inhibit protein synthesis at nanomolar concentrations in human colon tumor cells. Anticancer Drugs 2005, 16, 533–541. [Google Scholar] [CrossRef] [PubMed]
  93. Kwan, J.C.; Schmidt, E.W. Bacterial endosymbiosis in a chordate host: Long-term co-evolution and conservation of secondary metabolism. PLoS ONE 2013, 8, e80822. [Google Scholar] [CrossRef] [PubMed]
  94. Ueno, T.; Takahashi, H.; Oda, M.; Mizunuma, M.; Yokoyama, A.; Goto, Y.; Mizushina, Y.; Sakaguchi, K.; Hayashi, H. Inhibition of human telomerase by rubromycins: Implication of spiroketal system of the compounds as an active moiety. Biochemistry 2000, 39, 5995–6002. [Google Scholar] [CrossRef] [PubMed]
  95. Mehta, G.; Pan, S.C. First total synthesis of yanuthones: Novel farnesylated epoxycyclohexenoid marine natural products. Tetrahedron Lett. 2005, 46, 5219–5223. [Google Scholar] [CrossRef]
  96. Krick, A.; Kehraus, S.; Gerhäuser, C.; Klimo, K.; Nieger, M.; Maier, A.; Fiebig, H.H.; Atodiresei, I.; Raabe, G.; Fleischhauer, J.; König, G.M. Potential cancer chemopreventive in vitro activities of monomeric xanthone derivatives from the marine algicolous fungus Monodictys putredinis. J. Nat. Prod. 2007, 70, 353–360. [Google Scholar] [CrossRef] [PubMed]
  97. Geris, R.; Simpson, T.J. Meroterpenoids produced by fungi. Nat. Prod. Rep. 2009, 26, 1063–1094. [Google Scholar] [CrossRef] [PubMed]
  98. Shirai, M.; Okuda, M.; Motohashi, K.; Imoto, M.; Furihata, K.; Matsuo, Y.; Katsuta, A.; Shizuri, Y.; Seto, H. Terpenoids produced by actinomycetes: Isolation, structural elucidation and biosynthesis of new diterpenes, gifhornenolones A and B from Verrucosispora gifhornensis YM28-088. J. Antibiot. 2010, 63, 245–250. [Google Scholar] [CrossRef] [PubMed]
  99. Caboche, S.; Pupin, M.; Leclère, V.; Fontaine, A.; Jacques, P. NORINE: A database of nonribosomal peptides. Nucleic Acids Res. 2008, 36, D326–D331. [Google Scholar] [CrossRef] [PubMed]
  100. Chun, H.G.; Davies, B.; Hoth, D.; Suffness, M.; Plowman, J.; Flora, K.; Grieshaber, C.; Leyland-Jones, B. Didemnin B: The first marine compound entering clinical trials as an antineoplastic agent. Investig. New Drugs 1986, 4, 279–284. [Google Scholar] [CrossRef]
  101. Ireland, C.M.; Durso, A.R.; Newman, R.A.; Hacker, M.P. Antineoplastic cyclic peptides from the marine tunicate Lissoclinum patella. J. Org. Chem. 1982, 47, 1807–1811. [Google Scholar] [CrossRef]
  102. Williams, A.B.; Jacobs, R.S. A marine natural product, patellamide D, reverses multidrug resistance in a human leukemic cell line. Cancer Lett. 1993, 71, 97–102. [Google Scholar] [CrossRef]
  103. Mcdonald, L.A.; Ireland, C.M. Patellamide E: A new cyclic peptide from the ascidian Lissoclinum patella. J. Nat. Prod. 1992, 55, 376–379. [Google Scholar] [CrossRef] [PubMed]
  104. Rashid, M.A.; Gustafson, K.R.; Cardellina, J.H.I.; Boyd, M.R. Patellamide F, a new cytotoxic cyclic peptide from the colonial ascidian Lissoclinum patella. J. Nat. Prod. 1995, 58, 594–597. [Google Scholar] [CrossRef] [PubMed]
  105. Kawahara, T.; Takagi, M.; Shin-Ya, K. Three new depsipeptides, JBIR-113, JBIR-114 and JBIR-115, isolated from a marine sponge-derived Penicillium sp. fS36. J. Antibiot. 2011, 65, 147–150. [Google Scholar] [CrossRef] [PubMed]
  106. Zotchev, S.B. Alkaloids from marine bacteria. Adv. Bot. Res. 2013, 68, 301–333. [Google Scholar] [CrossRef]
  107. Powell, R.G.; Smith, C.R., Jr.; Weisleder, D.; Matsumoto, G.; Clardy, J.; Kozlowski, J. Sesbanimide, a potent antitumor substance from Sesbania drummondii seed. J. Am. Chem. Soc. 1983, 105, 3739–3741. [Google Scholar] [CrossRef]
  108. Powell, R.G.; Smith, C.R., Jr.; Weisleder, D. Sesbanimide A and related tumor inhibitors from Sesbania drummondii: Structure and chemistry. Phytochemistry 1984, 23, 2789–2796. [Google Scholar] [CrossRef]
  109. Cirillo, P.F.; Panek, J.S. Studies directed toward the synthesis of (+)-Sesbanimide A: Construction of the AB-ring system (a formal total synthesis). J. Org. Chem. 1994, 59, 3055–3063. [Google Scholar] [CrossRef]
  110. Atmaca, H.; Bozkurt, E. Trabectedin (ET-743) from Marine Tunicate for Cancer Treatment. In Handbook of Anticancer Drugs from Marine Origin; Springer: Berlin, Germany, 2015; pp. 397–412. [Google Scholar]
  111. Brodowicz, T. Trabectedin in soft tissue sarcomas. Future Oncol. 2014, 10, s1–s5. [Google Scholar] [CrossRef] [PubMed]
  112. Tamaoki, T.; Nomoto, H.; Takahashi, I.; Kato, Y.; Morimoto, M.; Tomita, F. Staurosporine, a potent inhibitor of phospholipid/Ca++ dependent protein kinase. Biochem. Biophys. Res. Commun. 1986, 135, 397–402. [Google Scholar] [CrossRef]
  113. Schupp, P.; Eder, C.; Proksch, P.; Wray, V.; Schneider, B.; Herderich, M.; Paul, V. Staurosporine derivatives from the ascidian Eudistoma toealensis and its predatory flatworm Pseudoceros sp. J. Nat. Prod. 1999, 62, 959–962. [Google Scholar] [CrossRef] [PubMed]
  114. Hayakawa, Y.; Shirasaki, S.; Shiba, S.; Kawasaki, T.; Mtsuo, Y.; Adachi, K.; Shizuri, Y. Piericidins C7 and C8, new cytotoxic antibiotics produced by a marine Streptomyces sp. J. Antibiot. 2007, 60, 196–200. [Google Scholar] [CrossRef] [PubMed]
  115. Mahyudin, N.A.; Blunt, J.W.; Cole, A.L.J.; Munro, M.H.G. The isolation of a new S-methyl benzothioate compound from a marine-derived Streptomyces sp. J. Biomed. Biotechnol. 2012, 2012, 894708. [Google Scholar] [CrossRef] [PubMed]
  116. Anahit, P.; Staffan, K.; Suhelen, E. Development of novel drugs from mrine surface associated microorganisms. Mar. Drugs 2010, 8, 438–459. [Google Scholar] [CrossRef]
  117. Schmidt, E.W.; Donia, M.S.; McIntosh, J.A.; Fricke, W.F.; Ravel, J. Origin and variation of tunicate secondary metabolites. J. Nat. Prod. 2012, 75, 295–304. [Google Scholar] [CrossRef] [PubMed]
  118. Kennedy, J.; Marchesi, J.R.; Dobson, A.D. Marine metagenomics: Strategies for the discovery of novel enzymes with biotechnological applications from marine environments. Microb. Cell Fact. 2008, 7, 27. [Google Scholar] [CrossRef] [PubMed]
  119. Zengler, K.; Walcher, M.; Clark, G.; Haller, I.; Toledo, G.; Holland, T.; Mathur, E.J.; Woodnutt, G.; Short, J.M.; Keller, M. High-throughput cultivation of microorganisms using microcapsules. Methods Enzymol. 2005, 397, 124–130. [Google Scholar] [CrossRef] [PubMed]
  120. Ben-Dov, E.; Kramarsky-Winter, E.; Kushmaro, A. An in situ method for cultivating microorganisms using a double encapsulation technique. FEMS Microbiol. Ecol. 2009, 68, 363–371. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  121. Steinert, G.; Whitfield, S.; Taylor, M.W.; Thoms, C.; Schupp, P.J. Application of diffusion growth chambers for the cultivation of marine sponge-associated bacteria. Mar. Biotechnol. 2014, 16, 594–603. [Google Scholar] [CrossRef] [PubMed]
  122. Palanisamy, S.K.; Rajendran, N.M.; Marino, A. Natural products diversity of marine ascidians (Tunicates; Ascidiacea) and successful drugs in clinical development. Nat. Prod. Bioprospect. 2017, 7, 1–111. [Google Scholar] [CrossRef] [PubMed]
Marinedrugs 16 00362 g001 550
Figure 1. Geographical distribution of ascidian samples used for the research of culturable microorganisms. The red circles represent the sampling sites of research: (A) Baja California; (B) Gulf of Mexico; (C) Caribbean Sea; (D) the coast of Brazil; (E) Antarctic Peninsula; (F) Mediterranean Sea; (G) Red Sea; (H) Maldives; (I) the Bay of Bengal; (J) Kuril Islands; (K) the Sea of Japan; (L) the Yellow Sea; (M) the South Sea; (N) Ryukyu Archipelago; (O) the southeast coast of Japan; (P) Guam; (Q) Palau; (R) Philippine; (S) Celebes Sea; (T) Singapore; (U) Caroline Islands; (V) Papua New Guinea; (W) Micronesian Islands; (X) the Great Barrier Reef; (Y) Fiji; (Z) Tasman Sea; (AA) New Zealand.
Figure 1. Geographical distribution of ascidian samples used for the research of culturable microorganisms. The red circles represent the sampling sites of research: (A) Baja California; (B) Gulf of Mexico; (C) Caribbean Sea; (D) the coast of Brazil; (E) Antarctic Peninsula; (F) Mediterranean Sea; (G) Red Sea; (H) Maldives; (I) the Bay of Bengal; (J) Kuril Islands; (K) the Sea of Japan; (L) the Yellow Sea; (M) the South Sea; (N) Ryukyu Archipelago; (O) the southeast coast of Japan; (P) Guam; (Q) Palau; (R) Philippine; (S) Celebes Sea; (T) Singapore; (U) Caroline Islands; (V) Papua New Guinea; (W) Micronesian Islands; (X) the Great Barrier Reef; (Y) Fiji; (Z) Tasman Sea; (AA) New Zealand.
Marinedrugs 16 00362 g001
Marinedrugs 16 00362 g002a 550Marinedrugs 16 00362 g002b 550Marinedrugs 16 00362 g002c 550Marinedrugs 16 00362 g002d 550Marinedrugs 16 00362 g002e 550Marinedrugs 16 00362 g002f 550Marinedrugs 16 00362 g002g 550Marinedrugs 16 00362 g002h 550Marinedrugs 16 00362 g002i 550Marinedrugs 16 00362 g002j 550
Figure 2. The chemical structures of 150 compounds.
Figure 2. The chemical structures of 150 compounds.
Marinedrugs 16 00362 g002aMarinedrugs 16 00362 g002bMarinedrugs 16 00362 g002cMarinedrugs 16 00362 g002dMarinedrugs 16 00362 g002eMarinedrugs 16 00362 g002fMarinedrugs 16 00362 g002gMarinedrugs 16 00362 g002hMarinedrugs 16 00362 g002iMarinedrugs 16 00362 g002j
Marinedrugs 16 00362 g003 550
Figure 3. Number of natural products isolated from ascidian-associated microorganisms up to 2017.
Figure 3. Number of natural products isolated from ascidian-associated microorganisms up to 2017.
Marinedrugs 16 00362 g003
Marinedrugs 16 00362 g004 550
Figure 4. Five groups of natural products isolated from ascidian-associated microorganisms.
Figure 4. Five groups of natural products isolated from ascidian-associated microorganisms.
Marinedrugs 16 00362 g004
Marinedrugs 16 00362 g005 550
Figure 5. Percentage distribution of bioactivities of natural products from ascidian-associated microorganisms.
Figure 5. Percentage distribution of bioactivities of natural products from ascidian-associated microorganisms.
Marinedrugs 16 00362 g005
Marinedrugs 16 00362 g006 550
Figure 6. Percentage distribution of natural products isolated from ascidian-associated microorganisms.
Figure 6. Percentage distribution of natural products isolated from ascidian-associated microorganisms.
Marinedrugs 16 00362 g006
Table
Table 1. Microorganism genera associated with ascidians.
Table 1. Microorganism genera associated with ascidians.
MicroorganismHost AscidianGeographical LocationReference
Bacteria
Acinetobacter sp.Stomozoa murrayiAO: Yucatan Peninsula, Mexico[12]
Didemnum ligulumAO: São Paulo, Brazil[30]
Agrobacterium sp.Ecteinascidia turbinataAO: mangroves of the Florida peninsula, US[31]
Polycitonidae sp.AO: Turkish coast[31]
Bacillus pumilusHalocynthia aurantiumPO: Sea of Japan[32,33]
Bacillus sp.Didemnum sp.AO: São Paulo, Brazil[30]
Didemnum ligulumAO: São Paulo, Brazil[30]
Candidatus Endoecteinascidia frumentensisEcteinascidia turbinateAO: Florida Keys[16]
Candidatus Endolissoclinum faulkneriLissoclinum patellaPO: Papua New Guinea, Solomon Islands and Fiji[34]
Endozoicomonas sp.Didemnum sp.AO: São Paulo, Brazil[30]
Exiguobacterium sp.Didemnum ligulumAO: São Paulo, Brazil[30]
Halomonas halocynthiaeHalocynthia aurantiumPO: Sea of Japan[35]
Hasllibacter halocynthiaeHalocynthia roretziPO: the coast of Gangneung, Korea[36,37]
Labilibacter aurantiacusStyela clavaPO: the Yellow Sea, China[38]
Paenibacillus sp.Didemnum ligulumAO: São Paulo, Brazil[30]
Paucisalibacillus sp.Didemnum ligulumAO: São Paulo, Brazil[30]
Pseudomonas stutzeriDidemnum sp.IO: Maldives[39]
Pseudomonas xanthomarinaHalocynthia aurantiumPO: Troitsa Bay, Peter the Great Bay, the Sea of Japan, Russia[39]
Pseudovibrio sp.Lissoclinum patellaAO: São Paulo, Brazil[30]
Rubritalea halochordaticolaUnidentifiedPO: Himezu Port, Sado Island, Niigata Prefecture, Japan[40]
Ruegeria halocynthiaeHalocynthia roretziPO: the South Sea, Korea[41]
Ruegeria sp.Didemnum sp.AO: São Paulo, Brazil[30]
Didemnum ligulumAO: São Paulo, Brazil[30]
Staphylococus sp.Didemnum ligulumAO: São Paulo, Brazil[30]
Stappia sp.Didemnum sp.AO: São Paulo, Brazil[30]
Didemnum ligulumAO: São Paulo, Brazil[30]
Tenacibaculum halocynthiaeHalocynthia roretziPO: the South Sea, Korea[42]
Tistrella mobilisTrididemnum solidumPO: Tateyama cove, Chiba, Japan[18]
IO: the Red Sea[19]
Vibrio sp.Polyclinum glabrumIO: Tuticorin coast[43]
Didemnum sp.AO: São Paulo, Brazil[30]
UnidentifiedUnidentifiedPO: Fiji[44]
Didemnum sp.AO: São Paulo, Brazil[30]
Didemnum ligulumAO: São Paulo, Brazil[30]
Ciona intestinalisNot mentioned[45]
Actinobacteria
Actinomadura sp.Ecteinascidia turbinataAO: Florida Keys[46]
Ecteinascidia turbinataNot mentioned[47]
Aeromicrobium halocynthiaeHalocynthia roretziPO: the coast of Gangneung, Korea[48]
Arthrobacter sp.Didemnum ligulumAO: São Paulo, Brazil[30]
Brevibacterium sp.Didemnum ligulumAO: São Paulo, Brazil[30]
Curtobacterium sp.Didemnum sp.AO: São Paulo, Brazil[30]
Didemnum ligulumAO: São Paulo, Brazil[30]
Gordonia didemniDidemnum sp.AO: São Paulo, Brazil[49]
Gordonia sp.Didemnum sp.AO: São Paulo, Brazil[30]
Kocuria sp.Didemnum ligulumAO: São Paulo, Brazil[30]
Micrococcus sp.Didemnum sp.AO: São Paulo, Brazil[30]
Didemnum ligulumAO: São Paulo, Brazil[30]
Micromonospora spp.Eudistoma vannameiAO: Taiba Beach northeastern coast of Brazi[50]
Nocardia sp.Trididemnum orbiculatumAO: Florida Keys[51]
UnidentifiedPO: Simushir Island, Kuril Islands[52]
Didemnum ligulumAO: São Paulo, Brazil[30]
Nocardiopsis dassonvilleiBotryllus schlosseriPO: the Yellow Sea, China[53]
Saccharopolyspora sp.UnidentifiedPO: Tateyama City, Chiba Prefecture, Japan[54]
Salinispora arenicolaEcteinascidia turbinataAO: Sweetings Cay, Grand Bahama Island[14]
Salinispora pacificaPolysyncraton lithostrotumNot mentioned[55,56]
Salinispora sp.Eudistoma toealensisPO: Islands of Chuuk and Pohnpei, Micronesia[57]
Solwaraspora sp.Trididemnum orbiculatumAO: Florida Keys[58]
Streptomyces hyaluromyciniMolgula manhattensisPO: Tokyo Bay, Japan[59]
Streptomyces sp.Aplidium lenticulumPO: Heron Island, Queensland, Australia[60]
Aplidium lenticulumPO: Great Barrier Reef, Australia[61]
Didemnum sp.IO: Obhur, Saudi Arabia[62]
Ecteinascidia turbinataAO: La Parguera, Puerto Rico[13]
Styela clavaPO: the Yellow Sea, China[53]
Styela canopusAO: the Bastimentos National Park in Bocas del Toro, Panama[63]
Verrucosispora sp.Eudistoma toealensisPO: Islands of Chuuk and Pohnpei, Micronesia[56]
Cyanobacteria
Prochloron didemniLissoclinum patellaPO: Palau[64]
Prochloron sp.Didemnum etiolumPO: nothren Great Barrier Reef and Philippine[27,65]
Didemnum mollePO: Fiji, Philippine, Palau Island, Lizard Island, northern Great Barrier Reef, Guam and Caroline Islands[27,65]
Diplosoma multipapillataPO: Fiji[27,65]
Diplosoma similisPO: Caroline Islands, Philippine, Palau, Guam, Norhern Great Barrier Reef and Singapore[65]
Diplosoma virensPO: Caroline Islands, Philippine, Palau and Norhern Great Barrier Reef[65]
Echinoclinum triangulumPO: Philippine[27,65]
Lissoclinum patellaPO: Davies Reef, Great Barrier Reef, Australia[66]
Lissoclinum patellaPO: Philippine, Palau and Guam[27,65]
Lissoclinum punctatumPO: Palau and Singapore
Lissoclinum voeltzkowiPO: Caroline Islands, Philippine, Palau and Guam[65]
Trididemnum clinidesPO: Philippine and Guam[27,65]
Trididemnum cyclopsPO: Palau and Caroline Islands[65]
Trididemnum miniatumPO: Norhern Great Barrier Reef[27,65]
Trididemnum nubilumPO: Philippine, Fiji and Great Barrier Reef[27,65]
Trididemnum paraclinidesPO: Palau[27,65]
Trididemnum paracyclopsPO: Palau, Philippine and Guam[65]
Trididemnum strigosumPO: Philippine[27,65]
Prochloron spp.Diplosoma similePO: Crawl Key; Isla Cristobal[67]
Lissoclinum patellaPO: Palau; Palau New Guinea[68]
Lissoclinum verrilliPO: Isla Cristobal[67]
Synechocystis dideminDidemnum spp.PO: Baja, California, Mexico[69]
Synechocystis sp.Didemnum viridePO: Philippine and Palau[27,70]
Trididemnum cyanophorumPO: Panama and Guadaloupe[27,70]
Trididemnum solidumAO: Galeta, Panama[27]
UnidentifiedTrididemnum clinidesPO: Okinawajima Island, Ryukyu, Archipelago, Japan[71]
Fungi
Acremonium sp.Ecteinascidia turbinataAO: Bahamas[72]
Alternaria sp.Cystodytes dellechiajeiAO: Mediterranean Sea[29]
Didemnum sp.AO: São Paulo, Brazil[30]
Aspergillus candidusUnidentifiedNot mentioned[73]
Aspergillus fumigatusPycnoclavella communisAO: Mediterranean Sea[29]
Aspergillus nigerAplidium sp.PO: Caesar’s Rock in Benga, Fiji[74]
Aspergillus sp.Cystodytes dellechiajeiAO: Mediterranean Sea[29]
Didemnum sp.AO: São Paulo, Brazil[30]
Eudistoma vannameiAO: Northeast Brazil[75]
Bionectria sp.Didemnum sp.AO: São Paulo, Brazil[30]
Pycnoclavella communisAO: Mediterranean Sea[29]
Botryosphaeria sp.Didemnum sp.AO: São Paulo, Brazil[30]
Botrytis cinereaCystodytes dellechiajeiAO: Mediterranean Sea[29]
Cladosporium sp.Cystodytes dellechiajeiAO: Mediterranean Sea[29]
Didemnum fulgensAO: Mediterranean Sea[29]
Didemnum sp.AO: São Paulo, Brazil[30]
Pycnoclavella communisAO: Mediterranean Sea[29]
Clonostachys sp.Didemnum fulgensAO: Mediterranean Sea[29]
Cochliobolus sp.Didemnum sp.AO: São Paulo, Brazil[30]
Cunninghamella sp.Didemnum sp.AO: São Paulo, Brazil[30]
Epicoccum nigrumCystodytes dellechiajeiAO: Mediterranean Sea[29]
Fusarium sp.Cystodytes dellechiajeiAO: Mediterranean Sea[29]
Didemnum sp.AO: São Paulo, Brazil[30]
Humicola fuscoatraUnidentifiedPO: Shikotan island, the Kuril isles[76]
Meyerozyma sp.Ciona intestinalisPO: the Yellow Sea, China[77]
Microdiplodia sp.Didemnum fulgensAO: L’Escala, Spain ‘La Depuradora’, Mediterranean Sea[29]
Mucor sp.Didemnum sp.AO: São Paulo, Brazil[30]
Penicillium brevicompactumCystodytes dellechiajeiAO: Mediterranean Sea[29]
Didemnum fulgensAO: Mediterranean Sea[29]
Penicillium rubensDidemnum fulgensAO: Mediterranean Sea[29]
Penicillium steckiiUnidentifiedAO: Mochima Bay, Mochima National Park and Paria Bay, Irapa, Venezuela[78]
Penicillium stoloniferumUnidentifiedPO: Jiaozhou Bay, Qingdao, China[79]
Penicillium sp.Cystodytes dellechiajeiAO: Mediterranean Sea[29]
Didemnum fulgensAO: Mediterranean Sea[29]
Didemnum mollePO: Ishigaki Island, Okinawa Prefecture, Japan[80]
Didemnum sp.AO: São Paulo, Brazil[30]
Pycnoclavella communisAO: Mediterranean Sea[29]
Pestalotiopsis sp.Didemnum sp.AO: São Paulo, Brazil[30]
Phoma sp.Cystodytes dellechiajeiAO: Mediterranean Sea[29]
Pycnoclavella communisAO: Mediterranean Sea[29]
Didemnum sp.AO: São Paulo, Brazil[30]
Pithomyces sp.Oxycorynia fascicularisIO and PO[81]
Plectosphaerella sp.Cystodytes dellechiajeiAO: Mediterranean Sea[29]
Rhizopus sp.Didemnum sp.AO: São Paulo, Brazil[30]
Scopulariopsis sp.Didemnum fulgensAO: Mediterranean Sea[29]
Talaromyces albobiverticillius (basionym: Penicillium albobiverticillium)UnidentifiedPO: Manado, Indonesia[82,83]
Talaromyces verruculosus (basionym: Penicillium verruculosum)Polycarpa aurataPO: Manado, Indonesia[83,84]
Talaromyces sp.Pycnoclavella communisAO: Mediterranean Sea[29]
UnidentifiedPO: Tweed Heads, NSW, Australia[85]
Trichoderma harzianumPycnoclavella communisAO: Mediterranean Sea[29]
Trichoderma virensDidemnum mollePO: Madang, Papua New Guinea[86]
Trichoderma sp.Didemnum fulgensAO: Mediterranean Sea[29]
Didemnum sp.AO: São Paulo, Brazil[30]
UnidentifiedDidemnum sp.AO: São Paulo, Brazil[30]
Unidentified (A fungus in the class Eurotiomycetes)Lissoclinum patellaPO: Papua New Guinea[87]
Symbols of world principal oceanic areas: AO, Atlantic Ocean; ArO, Arctic Ocean; IO, Indian Ocean; PO, Pacific Ocean; SO, Southern Ocean (Antarctic Ocean).

Share and Cite

MDPI and ACS Style

Chen, L.; Hu, J.-S.; Xu, J.-L.; Shao, C.-L.; Wang, G.-Y. Biological and Chemical Diversity of Ascidian-Associated Microorganisms. Mar. Drugs 2018, 16, 362. https://doi.org/10.3390/md16100362

AMA Style

Chen L, Hu J-S, Xu J-L, Shao C-L, Wang G-Y. Biological and Chemical Diversity of Ascidian-Associated Microorganisms. Marine Drugs. 2018; 16(10):362. https://doi.org/10.3390/md16100362

Chicago/Turabian Style

Chen, Lei, Jin-Shuang Hu, Jia-Lei Xu, Chang-Lun Shao, and Guang-Yu Wang. 2018. "Biological and Chemical Diversity of Ascidian-Associated Microorganisms" Marine Drugs 16, no. 10: 362. https://doi.org/10.3390/md16100362

APA Style

Chen, L., Hu, J. -S., Xu, J. -L., Shao, C. -L., & Wang, G. -Y. (2018). Biological and Chemical Diversity of Ascidian-Associated Microorganisms. Marine Drugs, 16(10), 362. https://doi.org/10.3390/md16100362

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop